ID   PDE6D_HUMAN             Reviewed;         150 AA.
AC   O43924; O43250;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   12-APR-2017, entry version 155.
DE   RecName: Full=Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta;
DE            Short=GMP-PDE delta;
DE   AltName: Full=Protein p17;
GN   Name=PDE6D; Synonyms=PDED;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9570951; DOI=10.1006/geno.1998.5210;
RA   Li N., Florio S.K., Pettenati M.J., Rao P.N., Beavo J.A., Baehr W.;
RT   "Characterization of human and mouse rod cGMP phosphodiesterase delta
RT   subunit (PDE6D) and chromosomal localization of the human gene.";
RL   Genomics 49:76-82(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9533031;
RA   Erchova G., Derre J., Chatelin S., Nancy V., Berger R., Kaplan J.,
RA   Munnich A., de Gunzburg J.;
RT   "cDNA sequence, genomic organization and mapping of PDE6D, the human
RT   gene encoding the delta subunit of the cGMP phosphodiesterase of
RT   retinal rod cells to chromosome 2q36.";
RL   Cytogenet. Cell Genet. 79:139-141(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9781033; DOI=10.1038/sj.ejhg.5200215;
RA   Lorenz B., Migliaccio C., Lichtner P., Meyer C., Strom T.M.,
RA   D'Urso M., Becker J., Ciccodicola A., Meitinger T.;
RT   "Cloning and gene structure of the rod cGMP phosphodiesterase delta
RT   subunit gene (PDED) in man and mouse.";
RL   Eur. J. Hum. Genet. 6:283-290(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH RAB13,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9712853; DOI=10.1074/jbc.273.35.22340;
RA   Marzesco A.M., Galli T., Louvard D., Zahraoui A.;
RT   "The rod cGMP phosphodiesterase delta subunit dissociates the small
RT   GTPase Rab13 from membranes.";
RL   J. Biol. Chem. 273:22340-22345(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH ARL3.
RX   PubMed=10518933; DOI=10.1016/S0014-5793(99)01117-5;
RA   Linari M., Hanzal-Bayer M., Becker J.;
RT   "The delta subunit of rod specific cyclic GMP phosphodiesterase, PDE
RT   delta, interacts with the Arf-like protein Arl3 in a GTP specific
RT   manner.";
RL   FEBS Lett. 458:55-59(1999).
RN   [8]
RP   INTERACTION WITH RPGR.
RX   PubMed=9990021; DOI=10.1073/pnas.96.4.1315;
RA   Linari M., Ueffing M., Manson F., Wright A., Meitinger T., Becker J.;
RT   "The retinitis pigmentosa GTPase regulator, RPGR, interacts with the
RT   delta subunit of rod cyclic GMP phosphodiesterase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:1315-1320(1999).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   INVOLVEMENT IN JBTS22, FUNCTION, INTERACTION WITH RPGR; ARL2; ARL3 AND
RP   INPP5E, AND SUBCELLULAR LOCATION.
RX   PubMed=24166846; DOI=10.1002/humu.22470;
RA   Thomas S., Wright K.J., Le Corre S., Micalizzi A., Romani M.,
RA   Abhyankar A., Saada J., Perrault I., Amiel J., Litzler J., Filhol E.,
RA   Elkhartoufi N., Kwong M., Casanova J.L., Boddaert N., Baehr W.,
RA   Lyonnet S., Munnich A., Burglen L., Chassaing N., Encha-Ravazi F.,
RA   Vekemans M., Gleeson J.G., Valente E.M., Jackson P.K., Drummond I.A.,
RA   Saunier S., Attie-Bitach T.;
RT   "A homozygous PDE6D mutation in Joubert syndrome impairs targeting of
RT   farnesylated INPP5E protein to the primary cilium.";
RL   Hum. Mutat. 35:137-146(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH MOUSE ARL2 AND
RP   GTP, AND INTERACTION WITH HRAS.
RX   PubMed=11980706; DOI=10.1093/emboj/21.9.2095;
RA   Hanzal-Bayer M., Renault L., Roversi P., Wittinghofer A., Hillig R.C.;
RT   "The complex of Arl2-GTP and PDE delta: from structure to function.";
RL   EMBO J. 21:2095-2106(2002).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH RHEB, FUNCTION,
RP   INTERACTION WITH RHEB; NRAS AND ARL2, AND SUBCELLULAR LOCATION.
RX   PubMed=22002721; DOI=10.1038/nchembio.686;
RA   Ismail S.A., Chen Y.X., Rusinova A., Chandra A., Bierbaum M.,
RA   Gremer L., Triola G., Waldmann H., Bastiaens P.I., Wittinghofer A.;
RT   "Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for
RT   farnesylated cargo.";
RL   Nat. Chem. Biol. 7:942-949(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH RPGR, FUNCTION,
RP   AND INTERACTION WITH RPGR.
RX   PubMed=23559067; DOI=10.1038/embor.2013.37;
RA   Watzlich D., Vetter I., Gotthardt K., Miertzschke M., Chen Y.X.,
RA   Wittinghofer A., Ismail S.;
RT   "The interplay between RPGR, PDE? and Arl2/3 regulate the ciliary
RT   targeting of farnesylated cargo.";
RL   EMBO Rep. 14:465-472(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS), FUNCTION, INTERACTION WITH
RP   RHEB AND KRAS, AND SUBCELLULAR LOCATION.
RX   PubMed=23698361; DOI=10.1038/nature12205;
RA   Zimmermann G., Papke B., Ismail S., Vartak N., Chandra A.,
RA   Hoffmann M., Hahn S.A., Triola G., Wittinghofer A., Bastiaens P.I.,
RA   Waldmann H.;
RT   "Small molecule inhibition of the KRAS-PDE? interaction impairs
RT   oncogenic KRAS signalling.";
RL   Nature 497:638-642(2013).
CC   -!- FUNCTION: Promotes the release of prenylated target proteins from
CC       cellular membranes (PubMed:9712853). Modulates the activity of
CC       prenylated or palmitoylated Ras family members by regulating their
CC       subcellular location (PubMed:22002721, PubMed:23698361). Required
CC       for normal ciliary targeting of farnesylated target proteins, such
CC       as INPP5E (PubMed:24166846). Modulates the subcellular location of
CC       target proteins by acting as a GTP specific dissociation inhibitor
CC       (GDI) (By similarity). Increases the affinity of ARL3 for GTP by
CC       several orders of magnitude. Stabilizes ARL3-GTP by decreasing the
CC       nucleotide dissociation rate (By similarity).
CC       {ECO:0000250|UniProtKB:O55057, ECO:0000269|PubMed:10518933,
CC       ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23559067,
CC       ECO:0000269|PubMed:23698361, ECO:0000269|PubMed:24166846,
CC       ECO:0000269|PubMed:9712853}.
CC   -!- SUBUNIT: Interacts with the prenylated catalytic subunits of PDE6,
CC       an oligomer composed of two catalytic chains (PDE6A and PDE6B) and
CC       two inhibitory chains (gamma); has no effect on enzyme activity
CC       but promotes the release of the prenylated enzyme from cell
CC       membrane (By similarity). Interacts with prenylated GRK1 and GRK7
CC       (By similarity). Interacts with prenylated Ras family members,
CC       including RAP2A and RAP2C (By similarity). Interacts with
CC       prenylated RHEB and NRAS (PubMed:22002721). Interacts with
CC       prenylated HRAS and KRAS. Interacts with RAB13 (prenylated form);
CC       dissociates RAB13 from membranes (PubMed:9712853). Interacts with
CC       prenylated INPP5E (PubMed:24166846). Interacts with RPGR
CC       (PubMed:9990021, PubMed:24166846, PubMed:23559067). Interacts with
CC       ARL2 (PubMed:24166846, PubMed:22002721). Interacts with ARL3; the
CC       interaction occurs specifically with the GTP-bound form of ARL3
CC       (PubMed:24166846). Interaction with ARL2 and ARL3 promotes release
CC       of farnesylated cargo proteins (PubMed:22002721).
CC       {ECO:0000250|UniProtKB:O55057, ECO:0000250|UniProtKB:Q95142,
CC       ECO:0000269|PubMed:10518933, ECO:0000269|PubMed:11980706,
CC       ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23559067,
CC       ECO:0000269|PubMed:23698361, ECO:0000269|PubMed:24166846,
CC       ECO:0000269|PubMed:9990021}.
CC   -!- INTERACTION:
CC       Q0P5N6:ARL16; NbExp=9; IntAct=EBI-712685, EBI-10186132;
CC       P36404:ARL2; NbExp=16; IntAct=EBI-712685, EBI-752365;
CC       Q9D0J4:Arl2 (xeno); NbExp=6; IntAct=EBI-712685, EBI-1033319;
CC       P36405:ARL3; NbExp=4; IntAct=EBI-712685, EBI-712710;
CC       Q9WUL7:Arl3 (xeno); NbExp=4; IntAct=EBI-712685, EBI-6860857;
CC       P51153:RAB13; NbExp=2; IntAct=EBI-712685, EBI-1780121;
CC       Q15382:RHEB; NbExp=5; IntAct=EBI-712685, EBI-6860739;
CC       Q92834:RPGR; NbExp=9; IntAct=EBI-712685, EBI-6558417;
CC       Q7DB77:tir (xeno); NbExp=3; IntAct=EBI-712685, EBI-6480811;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23698361,
CC       ECO:0000269|PubMed:9712853}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:9712853}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:9712853}. Cytoplasm, cytoskeleton, cilium
CC       basal body {ECO:0000269|PubMed:24166846}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Detected in various tissues
CC       including spleen, prostate gland, testis, ovary, small intestine,
CC       colon, retina, and peripheral blood. {ECO:0000269|PubMed:9712853}.
CC   -!- DISEASE: Joubert syndrome 22 (JBTS22) [MIM:615665]: A disorder
CC       presenting with cerebellar ataxia, oculomotor apraxia, hypotonia,
CC       neonatal breathing abnormalities and psychomotor delay.
CC       Neuroradiologically, it is characterized by cerebellar vermian
CC       hypoplasia/aplasia, thickened and reoriented superior cerebellar
CC       peduncles, and an abnormally large interpeduncular fossa, giving
CC       the appearance of a molar tooth on transaxial slices (molar tooth
CC       sign). Additional variable features include retinal dystrophy,
CC       renal disease, liver fibrosis, and polydactyly.
CC       {ECO:0000269|PubMed:24166846}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PDE6D/unc-119 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF045999; AAC39720.1; -; Genomic_DNA.
DR   EMBL; AF022912; AAB87872.1; -; mRNA.
DR   EMBL; AF042835; AAC25953.1; -; Genomic_DNA.
DR   EMBL; AF042833; AAC25953.1; JOINED; Genomic_DNA.
DR   EMBL; AF042834; AAC25953.1; JOINED; Genomic_DNA.
DR   EMBL; AJ001626; CAA04880.1; -; mRNA.
DR   EMBL; BT007278; AAP35942.1; -; mRNA.
DR   EMBL; BC007831; AAH07831.1; -; mRNA.
DR   CCDS; CCDS33398.1; -.
DR   RefSeq; NP_001277947.1; NM_001291018.1.
DR   RefSeq; NP_002592.1; NM_002601.3.
DR   UniGene; Hs.516808; -.
DR   PDB; 1KSG; X-ray; 2.30 A; B=1-150.
DR   PDB; 1KSH; X-ray; 1.80 A; B=1-150.
DR   PDB; 1KSJ; X-ray; 2.60 A; B=1-150.
DR   PDB; 3T5G; X-ray; 1.70 A; B=1-150.
DR   PDB; 3T5I; X-ray; 2.10 A; A/B/C/D=1-150.
DR   PDB; 4JHP; X-ray; 1.90 A; B=1-150.
DR   PDB; 4JV6; X-ray; 1.87 A; B=1-150.
DR   PDB; 4JV8; X-ray; 1.45 A; B=1-150.
DR   PDB; 4JVB; X-ray; 1.75 A; B=1-150.
DR   PDB; 4JVF; X-ray; 2.40 A; B=1-150.
DR   PDB; 5E80; X-ray; 2.60 A; A/B=2-150.
DR   PDB; 5E8F; X-ray; 2.10 A; A/C=2-150.
DR   PDB; 5F2U; X-ray; 1.85 A; A/B=2-150.
DR   PDB; 5ML2; X-ray; 1.60 A; B=2-150.
DR   PDB; 5ML3; X-ray; 1.40 A; B=2-150.
DR   PDB; 5ML4; X-ray; 2.40 A; B=2-150.
DR   PDB; 5ML6; X-ray; 1.87 A; B=2-150.
DR   PDB; 5ML8; X-ray; 2.60 A; B=2-150.
DR   PDB; 5TAR; X-ray; 1.90 A; B=3-150.
DR   PDB; 5TB5; X-ray; 2.00 A; B/D=1-150.
DR   PDBsum; 1KSG; -.
DR   PDBsum; 1KSH; -.
DR   PDBsum; 1KSJ; -.
DR   PDBsum; 3T5G; -.
DR   PDBsum; 3T5I; -.
DR   PDBsum; 4JHP; -.
DR   PDBsum; 4JV6; -.
DR   PDBsum; 4JV8; -.
DR   PDBsum; 4JVB; -.
DR   PDBsum; 4JVF; -.
DR   PDBsum; 5E80; -.
DR   PDBsum; 5E8F; -.
DR   PDBsum; 5F2U; -.
DR   PDBsum; 5ML2; -.
DR   PDBsum; 5ML3; -.
DR   PDBsum; 5ML4; -.
DR   PDBsum; 5ML6; -.
DR   PDBsum; 5ML8; -.
DR   PDBsum; 5TAR; -.
DR   PDBsum; 5TB5; -.
DR   ProteinModelPortal; O43924; -.
DR   SMR; O43924; -.
DR   BioGrid; 111173; 26.
DR   DIP; DIP-36660N; -.
DR   IntAct; O43924; 18.
DR   MINT; MINT-236371; -.
DR   STRING; 9606.ENSP00000287600; -.
DR   BindingDB; O43924; -.
DR   ChEMBL; CHEMBL3860; -.
DR   BioMuta; PDE6D; -.
DR   EPD; O43924; -.
DR   PaxDb; O43924; -.
DR   PeptideAtlas; O43924; -.
DR   PRIDE; O43924; -.
DR   DNASU; 5147; -.
DR   Ensembl; ENST00000287600; ENSP00000287600; ENSG00000156973.
DR   GeneID; 5147; -.
DR   KEGG; hsa:5147; -.
DR   CTD; 5147; -.
DR   DisGeNET; 5147; -.
DR   GeneCards; PDE6D; -.
DR   HGNC; HGNC:8788; PDE6D.
DR   HPA; HPA037433; -.
DR   HPA; HPA037434; -.
DR   MalaCards; PDE6D; -.
DR   MIM; 602676; gene.
DR   MIM; 615665; phenotype.
DR   neXtProt; NX_O43924; -.
DR   OpenTargets; ENSG00000156973; -.
DR   Orphanet; 2754; Joubert syndrome with orofaciodigital defect.
DR   PharmGKB; PA33136; -.
DR   eggNOG; KOG4038; Eukaryota.
DR   eggNOG; ENOG4110ZMQ; LUCA.
DR   GeneTree; ENSGT00390000000263; -.
DR   HOGENOM; HOG000007689; -.
DR   HOVERGEN; HBG053542; -.
DR   KO; K13758; -.
DR   OMA; STNTWQN; -.
DR   OrthoDB; EOG091G0SV1; -.
DR   PhylomeDB; O43924; -.
DR   TreeFam; TF314474; -.
DR   Reactome; R-HSA-5624958; ARL13B-mediated ciliary trafficking of INPP5E.
DR   ChiTaRS; PDE6D; human.
DR   EvolutionaryTrace; O43924; -.
DR   GeneWiki; PDE6D; -.
DR   GenomeRNAi; 5147; -.
DR   PRO; PR:O43924; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000156973; -.
DR   CleanEx; HS_PDE6D; -.
DR   ExpressionAtlas; O43924; baseline and differential.
DR   Genevisible; O43924; HS.
DR   GO; GO:0005929; C:cilium; TAS:Reactome.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; IEA:InterPro.
DR   GO; GO:0005095; F:GTPase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   Gene3D; 2.70.50.40; -; 1.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR008015; PDED_dom.
DR   InterPro; IPR017287; Rhodop-sen_GMP-Pdiesterase_dsu.
DR   Pfam; PF05351; GMP_PDE_delta; 1.
DR   PIRSF; PIRSF037825; GMP-Pdiesterase_delta; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell projection; cGMP; Ciliopathy; Complete proteome;
KW   Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Joubert syndrome;
KW   Membrane; Reference proteome; Sensory transduction; Vision.
FT   CHAIN         1    150       Retinal rod rhodopsin-sensitive cGMP
FT                                3',5'-cyclic phosphodiesterase subunit
FT                                delta.
FT                                /FTId=PRO_0000221208.
FT   REGION      144    150       Required for association with membranes.
FT                                {ECO:0000269|PubMed:9712853}.
FT   CONFLICT    117    117       M -> V (in Ref. 4; CAA04880).
FT                                {ECO:0000305}.
FT   CONFLICT    146    146       R -> G (in Ref. 4; CAA04880).
FT                                {ECO:0000305}.
FT   HELIX         3     13       {ECO:0000244|PDB:5ML3}.
FT   STRAND       15     24       {ECO:0000244|PDB:5ML3}.
FT   TURN         25     27       {ECO:0000244|PDB:5ML3}.
FT   STRAND       30     34       {ECO:0000244|PDB:5ML3}.
FT   STRAND       43     50       {ECO:0000244|PDB:5ML3}.
FT   HELIX        51     55       {ECO:0000244|PDB:5ML3}.
FT   STRAND       57     69       {ECO:0000244|PDB:5ML3}.
FT   STRAND       71     82       {ECO:0000244|PDB:5ML3}.
FT   STRAND       85     97       {ECO:0000244|PDB:5ML3}.
FT   STRAND      101    110       {ECO:0000244|PDB:5ML3}.
FT   HELIX       114    116       {ECO:0000244|PDB:3T5G}.
FT   HELIX       120    123       {ECO:0000244|PDB:5ML3}.
FT   TURN        124    126       {ECO:0000244|PDB:5ML3}.
FT   STRAND      127    135       {ECO:0000244|PDB:5ML3}.
FT   STRAND      138    150       {ECO:0000244|PDB:5ML3}.
SQ   SEQUENCE   150 AA;  17420 MW;  AB8D9309C33B4411 CRC64;
     MSAKDERARE ILRGFKLNWM NLRDAETGKI LWQGTEDLSV PGVEHEARVP KKILKCKAVS
     RELNFSSTEQ MEKFRLEQKV YFKGQCLEEW FFEFGFVIPN STNTWQSLIE AAPESQMMPA
     SVLTGNVIIE TKFFDDDLLV STSRVRLFYV
//
